Ignite Creation Date:
2024-05-05 @ 9:57 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00991146
Status:
COMPLETED
Last Update Posted:
2020-09-25
First Post:
2009-10-06
Brief Title:
Efficacy and Safety Study of Canakinumab Administered for 6 Months 24 Weeks in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-06
First Submit QC Date:
October 6 2009
Study First Post Date:
2009-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-23
Last Update Post Date:
2020-09-25
Last Update Post Date Type:
ACTUAL